| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
712.8090 | 716.8850 | 202.0070 | 530.6060 | 1,099.2250 |
| Cost of Revenue
|
-544.3200 | -553.0400 | -113.3760 | -355.6640 | -750.7400 |
|
Gross Profit
|
168.4890 | 163.8450 | 88.6310 | 174.9420 | 348.4850 |
| Selling, General and Administrative Expenses
|
-5,826.1900 | -6,575.3820 | -775.8460 | -262.2810 | -186.5000 |
| Depreciation, Amortization and Depletion
|
-2,531.5270 | -1,606.9810 | 0 | -- | -- |
| Other Income/Expense, Operating
|
9.0290 | 9.0290 | 20.0180 | 0 | 12.2470 |
|
Operating Income/Expenses
|
-8,348.6880 | -8,173.3340 | -755.8280 | -262.2810 | -174.2530 |
|
Total Operating Profit/Loss
|
-8,180.1990 | -8,009.4890 | -667.1970 | -87.3390 | 174.2320 |
| Total Net Finance Income/Expense
|
-13.2010 | -13.2610 | -47.4830 | -5.8580 | 0.0360 |
|
Non-Operating Income/Expenses, Total
|
-15.9210 | -13.2610 | -47.4830 | -5.8580 | 0.0360 |
|
Pretax Income
|
-8,196.1200 | -8,022.7500 | -714.6800 | -93.1970 | 174.2680 |
|
Provision for Income Tax
|
-0.0700 | -0.0660 | 0 | 0 | 0 |
|
Net Income from Continuing Operations
|
-8,196.1900 | -8,022.8160 | -714.6800 | -93.1970 | 174.2680 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-8,196.1900 | -8,022.8160 | -714.6800 | -93.1970 | 174.2680 |
|
Net Income after Non-Controlling/Minority Interests
|
-8,196.1900 | -8,022.8160 | -714.6800 | -93.1970 | 174.2680 |
|
Preferred/Other Stock Distribution
|
-715.2510 | -714.3940 | 0 | -- | -- |
|
Net Income Available to Common Stockholders
|
-8,911.4410 | -8,737.2100 | -714.6800 | -93.1970 | 174.2680 |
|
Diluted Net Income Available to Common Stockholders
|
-8,911.4410 | -8,737.2100 | -714.6800 | -93.1970 | 174.2680 |
| Basic EPS
|
-5.62 | -6.40 | -0.53 | -0.07 | 0.13 |
| Diluted EPS
|
-5.62 | -6.40 | -0.53 | -0.07 | 0.13 |
|
Basic Weighted Average Shares Outstanding
|
1,730.7150 | 1,356.4150 | 1,336.1110 | 1,336.1110 | 1,336.1110 |
|
Diluted Weighted Average Shares Outstanding
|
1,730.7150 | 1,356.4150 | 1,336.1110 | 1,336.1110 | 1,336.1110 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-8,182.9190 | -8,009.4890 | -667.1970 | -87.3390 | 174.2320 |
|
EBITDA
|
-5,651.3920 | -6,402.5080 | -667.1970 | -87.3390 | 174.2320 |
|
Normalized EBITDA
|
-4,958.9440 | -4,826.4890 | -649.4890 | -87.3390 | 174.2320 |
|
Normalized Income
|
-7,503.7420 | -6,446.7970 | -696.9720 | -93.1970 | 174.2680 |
|
Total Unusual Items
|
692.4480 | 1,576.0190 | 17.7080 | 0 | 0 |
|
Total Unusual Items Excluding Goodwill
|
692.4480 | 1,576.0190 | 17.7080 | 0 | 0 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
3/31/2023 - 5/21/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade